<DOC>
	<DOCNO>NCT01457352</DOCNO>
	<brief_summary>The purpose study ass whether SPARC0921 demonstrate efficacy safety treatment spasticity .</brief_summary>
	<brief_title>Efficacy Safety SPARC0921 Subjects With Spasticity</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<criteria>Men woman age 18 year old Known history spasticity due MS prior start baclofen Able willing comply protocol , include availability schedule clinic visit Willingness give write informed consent In relapse history unstable course prior 30 day prior Screening Visit Concomitant neurologic condition cause spasticity Has receive investigational drug device within 30 day would interfere study goal prior Screening Visit Unable comply study procedure opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Baclofen , spasticity</keyword>
</DOC>